Is it appropriate to prescribe nicotine patches for smoking cessation in a pregnant woman who smokes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nicotine Patches in Pregnancy: Clinical Recommendation

Behavioral counseling should be the first-line treatment for smoking cessation in pregnancy, but if this fails, nicotine patches may be prescribed under physician supervision after shared decision-making, as NRT is likely safer than continued smoking despite uncertain efficacy. 1, 2

Treatment Algorithm

Step 1: Initiate Intensive Behavioral Counseling First

  • All pregnant smokers must receive intensive behavioral counseling as the initial intervention, which increases cessation rates from approximately 11% to 15% in late pregnancy. 1, 2
  • Effective counseling requires at least 4 sessions with 91-300 minutes total contact time, providing messages tailored for pregnancy about maternal and fetal health effects, practical problem-solving skills, and strong advice to quit. 1, 2
  • Behavioral counseling alone reduces low birth weight (RR 0.83) and increases mean birth weight by 55.6 grams with no adverse events reported. 1, 2

Step 2: Consider NRT Only After Behavioral Counseling Fails

  • For pregnant women smoking ≤5 cigarettes per day: Use behavioral support only, do not prescribe NRT. 3
  • For pregnant women with moderate to high nicotine dependence who cannot quit with counseling alone: NRT patches may be prescribed under physician supervision through shared decision-making. 1, 2, 3

Evidence on NRT Efficacy and Safety

Limited Efficacy Data

  • Five placebo-controlled trials showed NRT trends toward benefit but no statistically significant increase in smoking cessation (11.9% with NRT vs 10.1% with placebo; RR 1.11,95% CI 0.79-1.56). 1
  • Adherence to NRT in pregnancy trials was extremely low (<10% in some studies), substantially limiting assessment of both efficacy and safety. 1, 4

Safety Considerations

  • NRT is FDA Pregnancy Category D (positive evidence of fetal risk, but potential benefits may warrant use). 2
  • NRT is believed safer than continued smoking because cigarette smoke contains thousands of chemicals including carbon monoxide and lead, whereas NRT delivers only nicotine. 1, 2
  • Reported adverse events with NRT include slightly increased diastolic blood pressure, skin reactions to patches, and low-risk cardiovascular events like tachycardia. 1, 2
  • Perinatal outcomes with NRT showed inconsistent and imprecise findings across trials. 1

Practical Implementation

Prescribing Guidelines

  • Minimum 12 weeks of therapy for initial quit attempt. 2
  • Schedule follow-up within 2 weeks after starting NRT. 2
  • Continue intensive behavioral counseling throughout NRT use—combination therapy is most effective. 2, 3
  • Strongly advise that NRT must be stopped if the mother resumes smoking to avoid dual exposure. 2

Shared Decision-Making Discussion Points

  • Emphasize that smoking during pregnancy causes documented severe harms: fetal growth restriction, preterm birth, low birth weight, stillbirth (25-50% increased risk), placental complications, and increased perinatal mortality. 1, 5
  • Explain that quitting early in pregnancy (before 15 weeks) provides greatest benefit and can reduce or eliminate adverse effects on fetal growth. 1, 5
  • Discuss that while NRT efficacy in pregnancy is uncertain, it likely poses less risk than continued smoking. 1, 2
  • Consider severity of tobacco dependence when weighing risks and benefits. 1

Critical Pitfalls to Avoid

  • Never prescribe NRT as first-line treatment without attempting behavioral counseling first. 2
  • Do not prescribe NRT to light smokers (≤5 cigarettes/day)—behavioral support alone is appropriate. 3
  • Do not recommend bupropion or varenicline in pregnancy—no safety or efficacy data exist for these agents. 1
  • Do not recommend e-cigarettes—no trials have evaluated them for smoking cessation in pregnancy, and they contain numerous potentially toxic substances. 1
  • Address postpartum relapse risk—approximately 50% of quitters relapse within 2 months after delivery and require ongoing support. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nicotine Replacement Therapy in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Nicotine replacement therapy during pregnancy: recommended or not recommended?

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2009

Research

A randomized trial of nicotine-replacement therapy patches in pregnancy.

The New England journal of medicine, 2012

Research

Smoking cessation strategies in pregnancy: Current concepts and controversies.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.